Aerovate is a Massachusetts-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cardiopulmonary disease.
Business Model:
Revenue: $0
Employees: 11-50
Address: 200 Berkeley Street
City: Boston
State: MA
Zip: 02116
Country: US
Aerovate is a Massachusetts-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cardiopulmonary disease.
Contact Phone:
+16174432400
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/29/2021
IPO Valuation:
$324M
Ticker Symbol:
AVTE
IPO Price:
$14/share
Amount Raised:
$122M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2020 | Series A | 5 | $72.6M |
Atlas Venture Cormorant Asset Management OUP (Osage University Partners) Sofinnova Investments Surveyor Capital Atlas Venture Cormorant Asset Management OUP (Osage University Partners) Sofinnova Investments Surveyor Capital |
1/2020 | Seed Round | 1 | - |
RA Capital Management RA Capital Management |
6/2021 | IPO | $121.5M |
|
12/2019 | Debt | $2.5M |
RA Capital Management |
1/2020 | Seed Round | 1 | - |
RA Capital Management RA Capital Management |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|